GVC Holdings to host the Safer Gambling Research Symposium at The British Academy

After a successful, multi-year research with the Cambridge Health Alliance, Harvard Medical School, GVC Holdings announced a symposium on research into safer gambling at the British Academy.

The symposium will be led by the faculty from the Division of Addiction of the Cambridge Health Alliance and it will outline the scope and ambition of the research to an invited audience of academics, researchers and iGaming and gambling industry leaders.

Professors, Dr Debi LaPlante and Dr Sarah E. Nelson will tackle the range of research that is currently being explored by the Division on Addiction using anonymized player data provided by GVC. The data comes from a broad range of areas including:

Patterns of Normal Internet Gambling Behavior…

Behavioral markers of harm, evaluating the effectiveness of algorithms deployed by GVC include:

• Safer Gambling limits and the affordability of online gambling
• Adopting an evidence-based approach to product safety
• Review of responsible gambling training and its effectiveness

There will also be a discussion led by Sarah Hanratty, CEO of the Senet Group and Paul Buck, CEO of EPIC Risk Management, Anna Hemmings, CEO of GemCare and Brigid Simmonds, Chair of the Betting and Gaming Council. This will tackle the topics of effectiveness of responsible gambling intervention messaging, the impact of operator’s responsible gaming tools as well as the ways that the industry can improve the detection of at-risk behaviors.

Kenny Alexander, CEO of GVC Holdings, who recently partnered with Playtech said: “As part of our Changing for the Bettor strategy, we at GVC are determined to advance the understanding of problem gambling so that we can more successfully intervene to minimize harm to potentially vulnerable individuals. Our partnership with Harvard Medical School’s Division on Addiction is vital to this process and we are delighted to be hosting today’s symposium to bring together so many people who share our ambition.”

Dr Debi LaPlante, Director at the Division of Addiction of the Cambridge Health Alliance, Harvard Medical School, said: “It is only by taking an evidence-based approach to examining gambling that we can develop better strategies and tools to limit its potential to cause harm. The collaboration with GVC that is at the heart of today’s symposium will play a significant role in advancing our knowledge about the issue of problem gambling and is warmly welcomed.”

More About GVC

GVC Holdings PLC is a gambling and online gambling operator that operates in both B2C and B2B markets. It is one of the world’s largest sports-betting and gaming groups and it is licensed in over 20 jurisdictions and has a current workforce of more than 25,000 experts in 20 offices across five continents.

The company is a member of FTSE 250. It offers a highly scalable and robust platform, proprietary sportsbook, casino, poker and bingo software. The Group owns a wide portfolio of well-established brands. Their sports brands include bwin, Coral, Crystalbet, Eurobet, Ladbrokes, Neds International and Sportingbet.

As far as games brands go, the Group owns CasinoClub, Foxy Bingo, Gala, Gioco Digitale, partypoker and PartyCasino. The Group holds ownerships for proprietary technology across all of its core product verticals and aside from their B2C operations they provide services to third-party customers on a B2B basis.

Source:

“GVC Hosts Safer Gambling Research Symposium with Harvard Medical School Faculty from the Division on Addiction at the British Academy”, gvc-plc.com, November 12, 2019.